JENNY BLACKMAN: Open Payments
NPI 1194295899 · LEAGUE CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,558 in 86 payments from 15 companies in 2025. Trend: 2023 $1,387 · 2024 $1,132 · 2025 $1,558
Food & beverage: $1,558
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 35 | $567 |
| Madrigal Pharmaceuticals | 16 | $190 |
| ABBVIE INC. | 9 | $158 |
| Gilead Sciences, Inc. | 7 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $86 |
| Mallinckrodt Hospital Products Inc. | 3 | $80 |
| Baxter Healthcare | 2 | $75 |
| La Jolla Pharmaceutical Company | 2 | $55 |
| Astellas Pharma US Inc | 2 | $51 |
| Genentech USA, Inc. | 2 | $49 |
Products named: XIFAXAN, REZDIFFRA, TEFLARO, LIVTENCITY, TERLIVAZ, PERCLOT, GIAPREZA, Cresemba.
Industry payments across TX — which companies pay providers there.
